Respiratory failure

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Here is a comprehensive overview of respiratory failure drawn from authoritative pulmonary and critical care textbooks.

Respiratory Failure

Definition

Respiratory failure is characterized by inadequate blood oxygenation or carbon dioxide removal — specifically the failure of the respiratory system to meet tissue requirements for oxygen uptake and CO₂ elimination. Clinically, it is defined by arterial blood gas values. — Fishman's Pulmonary Diseases and Disorders

Classification

Classification of Respiratory Failure
Respiratory failure is classified along two axes:

By Gas Exchange Abnormality

TypeDefinitionKey ABG Finding
Hypoxemic (Type 1)Failure to oxygenatePaO₂ < 60 mm Hg on room air
Hypercapnic (Type 2)Failure to ventilatePaCO₂ > 45–50 mm Hg
Postoperative (Type 3)Atelectasis-driven; subset of Type 1/2Occurs post-surgery from pain/sedation
Shock-related (Type 4)Metabolic demand exceeds respiratory capacitye.g., sepsis, fever
The two types frequently coexist — disorders initially causing hypoxemia may progress to pump failure and hypercapnia. — Washington Manual of Medical Therapeutics

By Time Course

AcuteChronic
HypercapnicPaCO₂ >45 mmHg + acidemia (pH <7.30); develops in minutes to hoursLong-standing CO₂ retention with renal HCO₃⁻ compensation
HypoxemicAbrupt change in mental status; develops rapidlyPolycythemia, cor pulmonale as clues

Pathophysiology

Respiratory failure can arise from any component of the respiratory pump or the alveoli:
Central Nervous System → Peripheral Nerves → Respiratory Muscles/Chest Wall → Airways → Alveoli
Defects in the first four (the "respiratory pump") tend to cause combined hypercapnia and hypoxemia; alveolar disorders initially cause predominantly hypoxemia. — Fishman's Pulmonary Diseases and Disorders

Mechanisms of Hypoxemia (Type 1)

MechanismExamplesA-a GradientO₂ Response
V/Q MismatchCOPD, pneumonia, PE, pulmonary edemaElevatedResponds to O₂
ShuntAtelectasis, ARDS, ASD/VSD, pneumoniaElevatedMinimal/no response
Diffusion limitationPulmonary fibrosis, pulmonary hypertensionElevatedResponds to O₂
HypoventilationCNS depression, neuromuscular diseaseNormalResponds to O₂
Low inspired O₂High altitudeNormalResponds to O₂

Causes of Hypercapnia (Type 2)

Hypercapnia follows the equation: PaCO₂ ∝ VCO₂ / VA — any decrease in alveolar ventilation (VA) or increase in dead space raises PaCO₂.
CNS ("won't breathe"): Opiate overdose, CNS infection, metabolic alkalosis, obesity-hypoventilation syndrome, meningoencephalitis, stroke
Neuromuscular ("can't breathe"): Guillain-Barré syndrome, myasthenia gravis, ALS, muscular dystrophies, spinal cord injury, pharmacologic paralysis
Chest wall/thoracic: Kyphoscoliosis, flail chest, morbid obesity, massive ascites, abdominal distension
Airway obstruction: COPD (most common), acute asthma, cystic fibrosis, epiglottitis, foreign body, tracheal tumor, bronchiolitis obliterans
Alveolar/parenchymal: Severe ARDS, extensive pneumonia, pulmonary edema — through increased dead space and ventilatory demand exceeding supply
Hypermetabolic states (increased CO₂ production): Sepsis, fever, thyrotoxicosis, seizures, serotonin syndrome

Severity Classification (in COPD Exacerbation)

SeverityRRWork of BreathingMental StatusHypoxemiaPaCO₂ / pH
No failure20–30/minNormalBaselineMild, responds to NCNormal
Acute RF>30/minIncreased, accessory musclesBaselineResponds to <35% FiO₂50–60 mmHg, pH >7.25
Severe RFAlteredRequires >35% FiO₂PaCO₂ >60 mmHg or pH ≤7.25
Rosen's Emergency Medicine

Management Overview

Non-invasive Oxygen Therapy

DeviceFiO₂ RangeNotes
Nasal cannula~24–44%+4% per L/min; max 6 L/min
Simple face mask35–55%Min 5 L/min to flush CO₂
Venturi mask24–50%Precise FiO₂ control
Non-rebreather maskUp to 80%Reservoir bag with one-way valve
HFNCUp to 100%, up to 60 L/minFlushes dead space, small PEEP effect; reduces intubation need in hypoxemic RF

Non-invasive Positive Pressure Ventilation (NPPV)

  • CPAP (5–15 cm H₂O): Prevents alveolar collapse; used in pulmonary edema, OSA
  • BiPAP: Reduces work of breathing; first-line for COPD exacerbation with acute hypercapnic RF (if cooperative and hemodynamically stable)
  • BiPAP starting settings: IPAP 5–10 cm H₂O above EPAP; EPAP 5 cm H₂O

Invasive Mechanical Ventilation

Indicated when:
  • Non-invasive methods fail
  • Patient cannot protect airway
  • Altered mental status
  • Hemodynamic instability
  • Acute hypercapnic RF with pH ≤7.25

ECMO

  • VV ECMO: Severe hypoxemic RF (e.g., refractory ARDS) with intact cardiac function
  • VA ECMO: Combined cardiac and respiratory failure
  • Reserved for cases where conventional ventilation fails
Washington Manual of Medical Therapeutics; Sabiston Textbook of Surgery; Murray & Nadel's Textbook of Respiratory Medicine

Key Distinguishing Points

  • Shunt is the one cause of hypoxemia that does not respond to supplemental oxygen — a critical clinical discriminator
  • Acute hypercapnia raises PaCO₂ abruptly with acidosis; chronic hypercapnia has a compensated (higher) bicarbonate with near-normal pH
  • HFNC has shown mortality benefit over standard O₂ in hypoxemic non-hypercapnic RF (90-day mortality improvement)
  • Obesity hypoventilation syndrome causes hypercapnia on a central basis — distinct from obstructive sleep apnea alone

ECMO detailed review

Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
This is a shared conversation. Sign in to Orris to start your own chat.